Direct Answer
This group covers laboratory testing and the services that follow a hospital stay, such as home health, skilled nursing and rehabilitation. Revenue comes from Medicare, insurers and referrals, so reimbursement rates and referral flow matter.
Industry Overview
Diagnostics & Post-Acute Care sits within the health care sector. The first numbers to compare across companies here are test volume or admissions, revenue per unit and payer mix and labor cost ratio. The outside forces that move them are listed under Primary Macro Drivers.
Key Industry Metrics
- Test volume or admissions: Number of lab tests performed or patients admitted to home health, nursing or rehab services. It is the basic demand measure; compare it with referral trends and local population growth.
- Revenue per unit and payer mix: Average payment per test or episode and the split among Medicare, insurers and other payers. Payment rules vary by payer, so mix shifts can change revenue without any change in volume.
- Labor cost ratio: Clinical and technical wages relative to revenue. A rising ratio signals wage inflation or staffing shortages that payment rate updates do not cover.
- Operating margin: Share of revenue left after operating costs. In regulated payment systems, changes in reimbursement rates feed directly into this figure, so compare it with rate update timing.
- Referral sources: Where patients come from, such as hospitals, physicians or health plans. Concentration in a few referrers or hospital-owned competitors makes volume vulnerable to one relationship ending.
Primary Macro Drivers
- Aging population and discharge volumes: More older patients leave hospitals needing tests, therapy and home or facility care, which raises admissions and test volume across this group.
- Medicare payment rule updates: Medicare sets rates for home health, skilled nursing and many tests, so annual updates move revenue per unit and margin directly.
- Hospital referral patterns: Hospitals decide where discharged patients go, so strong referral relationships raise admissions while lost ones reduce volume.
- Staff availability: Providers need nurses, therapists and technicians to fill demand, so staffing availability limits admissions and drives labor cost ratio.
Major Risks
- Medicare reimbursement cuts: Lower Medicare rates cut revenue per unit while labor costs keep rising, so margin falls; watch final payment rules and revenue per admission or test.
- Staffing shortages: Without enough clinicians, providers close beds or turn referrals away, which limits volume and raises premium labor spending; watch labor cost ratio.
- Regulatory audits: Government audits can lead to repayment demands and payment holds; watch legal proceedings notes and any reserve for refunds.
- Competition from hospital-owned services: Hospitals that run their own home health, rehab or labs steer patients inward, reducing referrals; watch referral sources and admissions.
Industry Characteristics
| Characteristic | Profile |
|---|---|
| Cyclicality | Defensive |
| Capital Intensity | Medium |
| Regulatory Intensity | High |
| Industry Maturity | Mature |
| Geographic Importance | U.S. |
Companies Associated with Diagnostics & Post-Acute Care
The SEC's Standard Industrial Classification has no code that describes diagnostics & post-acute care as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business.
| Company | SEC classification | Revenue | Growth | Net margin | Year |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. | Services-Medical Laboratories | $14.0 billion | 7.2% | 6.3% | FY 2025 |
| Quest Diagnostics Inc | Services-Medical Laboratories | $11.0 billion | 11.8% | 9.0% | FY 2025 |
| Encompass Health Corp | Services-Hospitals | $5.9 billion | 10.5% | 9.5% | FY 2025 |
Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the company directory and the health care hub.
Where to Go Next
The Diagnostics & Post-Acute Care guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.
More in Health Care
- Health Care sector overview
- Dialysis Centers
- Diagnostic Laboratories
- Digital Therapeutics
- Diagnostic Devices
- Drug Discovery Platforms
- Diabetes Devices
- Electronic Health Records
- Dermatology Pharmaceuticals
Put it to work
Frequently Asked Questions
What are the main KPIs for the Diagnostics & Post-Acute Care industry?
Key performance indicators for the Diagnostics & Post-Acute Care industry include: Test volume or admissions, Revenue per unit and payer mix, Labor cost ratio, Operating margin, Referral sources. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.
How cyclical is the Diagnostics & Post-Acute Care industry?
The Diagnostics & Post-Acute Care industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.
What are the biggest risks in the Diagnostics & Post-Acute Care industry?
The primary risks for Diagnostics & Post-Acute Care companies include: Medicare reimbursement cuts, Staffing shortages, Regulatory audits, Competition from hospital-owned services. Investors should assess each company's exposure to these factors and its track record of navigating them.